ENHANCING ONCOLOGY INVESTIGATION WITH INTEGRATED KRAS ASSAY SOLUTIONS AND RAS ASSAYS

while in the promptly evolving field of oncology analysis, accurate and productive mutation screening is very important for producing focused therapies. The KRAS solutions Platform plays a pivotal job in this landscape by presenting complete options for KRAS mutation profiling and Assessment. KRAS mutations, found in roughly ninety five% of RAS-lin